Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India

Favipiravir is one of the leading oral anti-viral treatment approved in various countries for the potential treatment of patients with mild to moderate COVID-19 disease.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33vQhJ6
via IFTTT